日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001)

一项针对接受 EGFR-TKI 治疗后出现渐进性、寡转移性或潜在进展的晚期非小细胞肺癌患者的 II 期试验,评估安罗替尼联合 EGFR-TKI 的疗效 (CTONG-1803/ALTER-L001)

Chen, Hua-Jun; Tu, Hai-Yan; Hu, Yanping; Fan, Yun; Wu, Guowu; Cang, Shundong; Yang, Yi; Yang, Nong; Ma, Rui; Jin, Gaowa; Xu, Ximing; Liu, Anwen; Tang, Shubin; Cheng, Ying; Yu, Yan; Xu, Chong-Rui; Zhou, Qing; Wu, Yi-Long

First-line camrelizumab plus pemetrexed and carboplatin for advanced non-squamous non-small-cell lung cancer with brain metastases (CAP-BRAIN): final results of a multicentre, open-label, single-arm, phase 2 trial in China

一线卡瑞利珠单抗联合培美曲塞和卡铂治疗伴脑转移的晚期非鳞状非小细胞肺癌(CAP-BRAIN):一项在中国开展的多中心、开放标签、单臂II期临床试验的最终结果

Hou, Xue; Zhou, Chengzhi; Wu, Guowu; Lin, Wen; Xie, Zhanhong; Zhang, Haibo; Yi, Jiqun; Lv, Jingye; Cheng, Fengzhuo; She, Fenglin; Chen, Likun

Effect of chemoradiotherapy on the dynamics of circulating lymphocyte subsets in patients with non-metastatic nasopharyngeal carcinoma

化疗放疗对非转移性鼻咽癌患者循环淋巴细胞亚群动态变化的影响

Yi, Lilan; Gu, Yinfang; Guo, Longhua; Zou, Xiaofang; Wu, Guowu

Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma

卡瑞利珠单抗联合化疗作为局部晚期、复发性或转移性食管鳞状细胞癌二线治疗的疗效和安全性

Gu, Yinfang; Zou, Xiaofang; Zhu, Junlin; Wu, Guowu

Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial

Benmelstobart、安罗替尼和化疗治疗广泛期小细胞肺癌:一项随机3期试验

Cheng, Ying; Chen, Jianhua; Zhang, Wei; Xie, Chao; Hu, Qun; Zhou, Ningning; Huang, Chun; Wei, Shihong; Sun, Hong; Li, Xingya; Yu, Yan; Lai, Jinhuo; Yang, Huaping; Fang, Haohui; Chen, Hualin; Zhang, Peng; Gu, Kangsheng; Wang, Qiming; Shi, Jianhua; Yi, Tienan; Xu, Xingxiang; Ye, Xianwei; Wang, Daqing; Xie, Conghua; Liu, Chunling; Zheng, Yulong; Lin, Daren; Zhuang, Wu; Lu, Ping; Yu, Guohua; Li, Jinzhang; Gu, Yuhai; Li, Baolan; Wu, Rong; Jiang, Ou; Wang, Zaiyi; Wu, Guowu; Lin, Haifeng; Zhong, Diansheng; Xu, Yanhua; Shu, Yongqian; Wu, Di; Chen, Xingwu; Wang, Jie; Wang, Minghui; Yang, Runxiang

Refractory hypokalemia and metabolic acidosis induced by undifferentiated connective tissue disease secondary to immune checkpoint inhibitors: a case report and literature review

免疫检查点抑制剂继发未分化结缔组织病引起的难治性低钾血症和代谢性酸中毒:病例报告及文献综述

Gu, Yinfang; Yi, Lilan; Zou, Xiaofang; Guo, Longhua; Wu, Guowu; Zhao, Jingjing

Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized, Multicenter, Phase 3 Study

吉非替尼联合化疗对比吉非替尼单药治疗未经治疗的EGFR突变型非小细胞肺癌脑转移患者:GAP BRAIN开放标签、随机、多中心3期研究

Hou, Xue; Li, Meichen; Wu, Guowu; Feng, Weineng; Su, Jin; Jiang, Honghua; Jiang, Guanming; Chen, Jing; Zhang, Baishen; You, Zhixuan; Liu, Qing; Chen, Likun

The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients

中国非小细胞肺癌(NSCLC)患者RET融合阳性肿瘤的基因组特征

Wu, Guowu; Guo, Longhua; Gu, Yinfang; Huang, Tanxiao; Liu, Ming; Zou, Xiaofang; Yang, Bo; Huang, Ping; Wen, Chunling; Yi, Lilan; Liao, Wenting; Zhao, Dongdong; Zhu, Junlin; Zhang, Xiaoni; Liu, Yuanyuan; Yin, Yan; Chen, Shifu

Bioinformatics Analysis and Screening of Potential Target Genes Related to the Lung Cancer Prognosis.

肺癌预后相关潜在靶基因的生物信息学分析与筛选

Huang Ping, Gu Yinfang, Guo Longhua, Zou Xiaofang, Yi Lilan, Wu Guowu

KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer

KRAS/NRAS 突变与结直肠癌远处转移相关,BRAF/PIK3CA 突变与结直肠癌肿瘤分化不良相关

Zeng, Juanzi; Fan, Wenwei; Li, Jiaquan; Wu, Guowu; Wu, Heming